Source: LaingBuisson

Ethypharm: France: Ethypharm to enter Spanish market with acquisition of Altan Pharma

Ethypharm, a European pharmaceutical company focused on the therapeutic areas of the central nervous system and critical care headquartered in France, is making a move into the Spanish market by entering into a definitive agreement to acquire Altan Pharma, a specialty pharmaceutical company that develops, manufactures and markets injectable medicines for hospital use. With the [...]

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Bertrand Deluard's photo - CEO of Ethypharm

CEO

Bertrand Deluard

CEO Approval Rating

81/100

Read more